News >

Phasing Out Doublet Regimens in Relapsed/Refractory Multiple Myeloma

Jessica Hergert
Published: Wednesday, Feb 12, 2020

Barry Paul, MD, a physician in the Plasma Cells Disorders Group, Levine Cancer Institute, Atrium Health

Barry Paul, MD

Various triplet and quadruplet strategies that have moved through the pipeline are replacing the role of doublet regimens for patients with relapsed/refractory multiple myeloma, according to Barry Paul, MD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication